On the metabolizing systems for short-term genotoxicity assays: A review

Mutation Research - Reviews in Mutation Research

Volumn 387, Issue 1, 1997, Pages 17-34

  Paolini, Moreno ^a,b   Cantelli Forti, Giorgio ^a,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; MUTAGENIC AGENT; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL CULTURE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; GENOTOXICITY; LIVER MICROSOME; METABOLIC ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STORAGE;

ANIMALIA;

EID: 0030813923     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(97)00020-3     Document Type: Article

References (96)

1. Ashby, J. (1992) Use of short-term tests in determining the genotoxicity or non genotoxicity of chemicals, in: H. Vainio, P.N. Magee, D.B. McGregor and A.J. Michael (Eds.), Mechanisms of Carcinogenesis in Risk Identification, International Agency for Research on Cancer (IARC), Lyon, pp. 135-164.
2. B.L. Lave, F.K. Ennever, H.S. Rosenkranz, G.S. Omenn, Information value of the rodent bioassay, Nature 336 (1988) 631-633.
3. H.W. Malling, The mutagenicity of the acridine mustard (ICR-70) and the structurally related compound in Neurospore, Mutation Res. 4 (1967) 265-269.
4. M. Paolini, G.L. Biagi, G. Cantelli-Forti, C. Bauer, Comparison between in vivo and in vitro systems: the in vivo equivalent dose concept, Mutagenesis 3 (1988) 527-531.
5. B.L. Lave, G.S. Omenn, Cost-effectiveness of short-term tests for carcinogenicity, Nature 324 (1986) 29-34.
6. M. Paolini, G.L. Biagi, C. Bauer, G. Cantelli-Forti, On the procedure for isolation of S9 fractions from induced rodents in in vitro genotoxicity assays, Teratog. Carcinog. Mutag. 14 (1994) 101-103.
7. M. Paolini, C. Bauer, P. Corsi, R. Del Carratore, R. Nieri, G. Bronzetti, Stability of microsomal monooxygenase during incubations for the liver microsomal assay with S9 fractions of mouse liver under various induction, Mutation Res. 129 (1983) 221-230.
8. E.C. Miller, Y.A. Miller, Searches for ultimate chemical carcinogens and their reactions with cellular molecules, Cancer 47 (1981) 2327-2345.
9. B. Singer, Y.M. Essigmann, Site-specific mutagenesis, retrospective and prospective, Carcinogenesis 12 (1991) 949-955.
10. E.R. Fearon, S.R. Hamilton, B. Vogelstein, Clonal analysis of human colorectal tumors, Science 238 (1987) 193-197.
11. M. Hollstein, P. Sidransky, B. Vogelstein, C.C. Harris, P53 Mutations in human cancers, Science 253 (1991) 49-53.
12. B. Vogelstein, A deadly inheritance, Nature 348 (1990) 681-682.
13. F.P. Guengerich, Metabolic activation of carcinogens, Pharmacol. Ther. 54 (1992) 17-61.
14. A.W. Wood, W. Levin, A.Y.H. Lu, H. Yagi, O. Hernandez, D.M. Jerina, A.H. Conney, Metabolism of benzo[a]pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes, J. Biol. Chem. 251 (1976) 4882-4890.
15. Kasper, C.B. and D. Henton (1980) Glucuronidation, in: W.B. Jacoby (Ed.), Enzymatic Basis of Detoxification, Academic Press, New York, pp. 3-12.
16. C.R. Wolf, P.N. Berry, J.A. Nash, T. Green, E.A. Lock, Role of microsomal and cytosolic glutathione S-transferase in conjugation of hexachlor-1:3-butadiene and its possible relevance to toxicity, J. Pharmacol. Exp. Ther. 228 (1984) 202-208.
17. M. Runge-Morris, J. Wilusz, Suppression of hydroxysteroid sulfotransferase - a gene expression by 3-methylcholanthrene, Toxicol. Appl. Pharmacol. 125 (1994) 133-141.
18. P.E. Hanna, R.B. Banks, V.P. Marhevka, Suicide inactivation of hamster hepatic arylhydroxamic acide N,O-acyltransferase: a selective probe of N-acetyltransferase multiplicity, Mol. Pharmacol. 21 (1992) 159-168.
19. F.P. Guengerich, Enzymatic activation of chemicals to toxic metabolites, CRC Crit. Rev. Toxicol. 14 (1985) 259-307.
20. M. Paolini, C. Bauer, G.L. Biagi, G. Cantelli-Forti, Do cytochromes P448 and P450 have different functions?, Biochem. Pharmacol. 38 (1989) 2223-2225.
21. T. Yerokun, J.L. Etheredge, T.R. Norton, H.A. Carter, K.H. Chung, P.J. Birckbichler, D.P. Ringer, Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stage of 2-acetyl-aminofluorene-induced hepatocarcinogenesis, Cancer Res. 52 (1992) 4779-4786.
22. J.M. Patel, E. Ortiz, K.T. Shivetick, K.C. Liebman, Stability of drug metabolizing activities in lyophilized liver and lung preparations, Mutagenesis 2 (1983) 397-409.
23. D. Gatehause, Guidelines for testing of environmental agents. Critical features of bacterial mutation assays, Mutagenesis 2 (1987) 397-409.
24. A.L. Goldberg, A.C.S. John, Intracellular protein degradation in mammalian and bacterial cells: part 2, Annu. Rev. Biochem. 45 (1976) 747-768.
25. K. Sogawa, Y. Ichihara, K. Takahashi, Comparison of some characteristics of membrane bound neutral proteinase activity in the microsomal fraction of rat kidney and small intestine, J. Biochem. 90 (1981) 1243-1248.
26. J.G. Dent, S. Schvell, M.E. Graichen, P. Allen, D. Abernethy, D.B. Couch, Stability of activating systems for in vitro mutagenicity assay: enzyme activity and activating ability following long-term storage at -85°C, Environ. Mutagen. 3 (1981) 167-179.
27. C. Bauer, C. Corsi, M. Paolini, Stability of microsomal monooxygenases in murine liver S9 fractions derived from phenobarbital and b-naphthoflavone induced animals under various long-term conditions of storage, Teratog. Carcinog. Mutag. 14 (1994) 13-22.
28. J. Bartosek, E. Dolfini, P. Ghersa, A. Guaitani, P. Villa, S. Villa, Preservation of rat hepatic microsomal enzyme activities: effect of low temperature and freeze-drying, Pharmacol. Methods 3 (1980) 191-192.
29. A. Hubbards, P.J.B. Davis, Characterization of S9 fractions used in the third UKEMS collaborative trial, Mutagenesis 5 (1990) 7-8.
30. B.N. Ames, W.E. Dursto, E. Yamasaki, F.D. Lee, Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection, Proc. Natl. Acad. Sci. USA 70 (1973) 2281-2285.
31. Matsushima, T., M. Sawamura, K. Hara and T. Sugimura (1976) A safe substitute for polychlorinated biphenyls as an inducer of metabolic activation system, in: F.J. De Serres, J.R. Fouts, J.R. Bend and R.M. Philpot (Eds.), In Vitro Metabolic Activation in Mutagenesis Testing, Elsevier, Amsterdam, pp. 85-88.
32. A.P. Alvares, D.R. Bickers, A. Kappas, Polychlorinated biphenyls: a new type of inducer of cytochrome P448 in the liver, Proc. Natl. Acad. Sci. USA 70 (1973) 1321-1325.
33. D.M. Miller, A.E. Aust, R. Voorman, S.D. Aust, Inhibition of 2-aminofluorene mutagenesis in bacteria by inducers of cytochrome P450d, Carcinogenesis 9 (1988) 327-329.
34. T. Ong, M. Mukhtar, C.R. Wolf, E. Zeiger, Differential effects of cytochrome P450 inducers on premutangens activation capabilities and enzymatic activities of S9 from rat liver, J. Environ. Pathol. Toxicol. 4 (1980) 55-65.
35. M. Paolini, E. Sapigni, P. Hrelia, S. Grilli, G. Cantelli-Forti, Isolation of S9 fractions from mouse and rat with increased enzyme activities after repeated administration of cytochrome P450 and P448 inducers, Mutagenesis 3 (1988) 239-243.
36. U.K. Kleeberg, M. Sommer, W. Klinger, Increased response of cytochrome P450 dependent biotransformation reactions in rat liver to repeated administration of inducers, Arch. Toxicol. 8 (1985) 361-365.
37. I.R. Phillips, E.A. Shepard, R.M. Bayney, S.F. Pike, B.R. Rabin, R. Heat, N. Carter, Induction and repression of the major phenobarbital induced cytochrome P450 measured by radioimmunoassay, Biochem. J. 212 (1983) 55-64.
38. F. Heubel, F. Kehl, A. Von Maxen, Is there a pleitropic response in barbiturate induction?, Biochem. Pharmacol. 35 (1986) 1883-1889.
39. F.P. Guengerich, G.A. Dannas, S. Tracy Wright, M.V. Martin, S.L. Kaminski, Purification and characterization of liver microsomal cytochrome P450: electrophoretic, spectral, catalytic and immunochemical properties and inducibility of eight isoenzymes isolated from rats treated with phenobarbital or b-naphthoflavone, Biochemistry 21 (1982) 6019-6030.
40. F.P. Guengerich, Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy, Cancer Res. 48 (1988) 2946-2954.
41. M. Paolini, E. Sapigni, P. Hrelia, M. Scotti, M. Morotti, G. Cantelli-Forti, Wide spectrum detection of precarcinogens in short-term bioassays by simultaneous superinduction of multiple forms of cytochrome P450 isoenzymes, Carcinogenesis 12 (1991) 759-766.
42. R.G. Thurman, R. Scholz, Control of mixed fuction oxygenases in perfused rat liver, Pharmacologist 11 (1969) 260.
43. S. Booth, A.M. Welch, R.C. Garner, Some factors affecting mutant numbers in the Salmonella/microsome assay, Carcinogenesis 1 (1980) 911-923.
44. A.G. Miller, J.P. Withlock, Efficient metabolism of benzo[a]pyrene at nanomolar concentration by intact murine hepatoma cells, Cancer Res. 42 (1982) 4473-4478.
45. I.J. Sadowski, F.C. Wright, L.G. Israel, A premetabolized cell system for studying regulation of aryl hydrocarbon hydroxylase: NADPH as rate limiting factor in benzo[a]pyrene metabolism, Int. J. Biochem. 17 (1985) 1023-1025.
46. F.C. Kauffman, R.K. Evans, L.A. Reike, S.A. Belinski, C. Ballow, R.C. Thurman, Effects of 3-methylcholanthrene on oxidized nicotinamide-adenine dinucleotide phosphate-dependent dehydrogenase and selected metabolites in perfused rat liver, Biochem. Pharmacol. 26 (1980) 697-700.
47. D.W. Nebert, H.V. Gelboin, Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. Assay and properties of induced enzyme, J. Biol. Chem. 243 (1968) 6242-6249.
48. J.G. Conway, F.C. Kauffman, R.G. Thurman, Genetic regulation of NADPH supply in perfused mouse liver: role of the Ah locus during induction by 3-methylcholanthrene, J. Biol. Chem. 258 (1983) 3825-3831.
49. R.G. Thurman, D.P. Marazzo, L.S. Jogenes, F.C. Kauffman, The continuous kinetic determination of p-nitroanisole O-demethylase in hemoglobin-free perfused rat liver, J. Pharmacol. Ther. 201 (1977) 499-506.
50. R.G. Thurman, F.C. Kauffman, Factors regulating drug metabolism in intact hepatocytes, Pharmacol. Rev. 31 (1979) 229-252.
51. B.N. Ames, J. McCann, E. Yamasaki, Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test, Mutation Res. 31 (1975) 347-365.
52. G. Cantelli-Forti, M. Paolini, P. Hrelia, C. Corsi, G.L. Biagi, G. Bronzetti, NADPH-generating system: influence on microsomal monooxygenase stability during incubations for the liver-microsomal assay with rat and mouse S9 fractions, Mutation Res. 129 (1984) 291-297.
53. M. Paolini, P. Hrelia, C. Corsi, G. Bronzetti, G.L. Biagi, G. Cantelli-Forti, NADPH as rate-limiting factor for microsomal metabolism. An alternative and economic NADPH-generating system for microsomal monooxygenases in in vitro genotoxicity studies, Mutation Res. 178 (1987) 11-20.
54. R.L. Veech, K. Guynn, D. Veloso, The time course in the effects of ethanol on the redox and phosphorylation states of rat liver, Biochem. J. 127 (1972) 387-397.
55. E.A. Kosenko, Y.G. Kaminsky, A comparison between effects of chronic ethanol consumption, ethanol withdrawal and fasting in ethanol-fed rats on the free cytosolic NADP+ /NADPH ratio and NADPH-regenerating enzyme activities in the liver, Int. J. Biochem. 17 (1985) 895-902.
56. B.S. Cohen, R.W. Estabrook, Microsomal electron transport reactions. I Interaction of reduced triphophopyridine nucleotide during the oxidative demethylation of aminopyrine and cytochrome b5 reduction, Arch. Biochem. Biophys. 143 (1971) 37-45.
57. T. Sugiyama, N. Miki, T. Yamano, NADH- and NADPH-dependent reconstituted p-nitroanisole O-demethylation system containing cytochrome P450 with high affinity for cytochrome b5, J. Biochem. 87 (1980) 1457-1467.
58. M. Paolini, E. Sapigni, P. Hrelia, S. Grilli, G. Lattanzi, M. Scotti, G. Cantelli-Forti, Strategies for optimization of short-term genotoxicity tests: the synergistic effect of NADPH and NADH on P450 function in processing premutagens, Mutagenesis 5 (1990) 51-54.
59. Aust, D.S. and B.A. Svingen (1982) The role of iron in enzymatic lipid peroxidation, in: W.A. Pryor (Ed.), Free Radical in Biology, Vol. 5, Academic Press, New York. pp. 1-28
60. E.D. Wills, Lipid peroxide formation in microsomes, Biochem J. 113 (1969) 325-332.
61. D.J. Kronbrust, R.D. Mavis, Microsomal lipid peroxidation. 1. Characterization of the role of iron and NADPH, Mol. Pharmacol. 97 (1980) 400-407.
62. M. Paolini, F. Tonelli, C. Bauer, G. Bronzetti, C. Corsi, G. Cantelli-Forti, EDTA affects cytochrome P450-dependent biotransformation reactions during incubations for liver microsomal assays, Mutation Res. 208 (1988) 189-194.
63. M.M. Iba, G.J. Mannering, NADPH and linoleic acid hydroperoxide-induced lipid peroxidation and destruction of cytochrome P450 in hepatic microsomes, Biochem. Pharmacol. 36 (1987) 1447-1456.
64. Cheeseman, K.H. (1982) Effects of scavengers and inhibitors on lipid peroxidation in rat liver microsomes, in: D.C.H. McBrien and T.F. Slater (Eds.), Free Radicals, Lipid Peroxidation and Cancer, Academic Press, New York, pp. 197-214.
65. K. Heindorff, O. Aurich, A. Michaelis, R. Rieger, Genetic toxicology of ethylenediaminetetraacetic acid (EDTA), Mutation Res. 115 (1983) 149-173.
66. C. Mannironi, E. Cundari, C. Bauer, R. Del Carratore, G. Bronzetti, C. Corsi, R. Nieri, M. Paolini, Study of the optimal temperature for the liver microsomal assay with mice S9 fractions, Mutation Res. 147 (1985) 231-235.
67. W. Duppel, V. Ullrich, Membrane effects on drug monooxygenation activity in hepatic microsomes, Biochem. Biophys. 426 (1976) 399-407.
68. C.S. Yang, F.S. Strickhart, L.P. Kicka, The effects of temperature on monooxygenase reactions in the microsomal membrane, Biochem. Biophys. 465 (1976) 362-370.
69. P. Anzenbacher, J. Hudecek, R. Struzinsky, Study of thermal stability of cytochrome P-450 by differential scanning calorimetry, FEBS Lett. 49 (1982) 208-210.
70. M. Paolini, E. Sapigni, P. Hrelia, S. Grilli, G. Lattanzi, G. Cantelli-Forti, Improvement of short-term tests for mutagenicity: on the optimal pH for the liver microsomal assay, Carcinogenesis 9 (1988) 2265-2270.
71. N.B. Beaty, D.P. Ballou, Transient kinetic study of liver microsomal FAD-containing monooxygenase, J. Biol. Chem. 2551 (1980) 3817-3819.
72. D.W. Nebert, G.S. Pelton, Importance of genetic factors influencing the metabolism of foreign compounds, Fed. Proc. 17 (1976) 1133-1141.
73. Zannoni, V.G. (1971) Microsomal p-nitroanisole O-demethylase, in: B.N. LaDu, H.L. Mandel and E.L. Way (Eds.), Fundamentals of Drug Metabolism and Drug Disposition, Williams and Wilkins, Baltimore, MD, pp. 566-569.
74. J.B. Gettenplan, Enhanced mutagenic activities of N-nitroso compounds in weakly acidic media, Carcinogenesis 1 (1980) 439-444.
75. R.F. Addison, P.F. Brodie, Characterization of ethoxyresorufin O-deethylase in grey seal Halichaerus grypus, Comp. Biochem. Physiol. 79 (1984) 261-263.
76. H. Shigematsu, S. Yamano, H. Yoshimura, NADH-dependent O-deethylation of p-nitrophenetole with rabbit liver microsomes, Arch. Biochem. Biophys. 173 (1976) 178-186.
77. Beyl, F.E. and A. Sinharay (1980) Use of methylbayapanine as a substrate for microsomal O-demethylase, in: M.J. Coon, A.H., Conney, R.W. Estabrook, H.V. Gelboin, J.R. Gillette and P.J. O'Brien (Eds.), Microsomes, Drug Oxidations, and Chemical Carcinogenesis, Vol. 1, Academic Press, New York, pp. 111-118.
78. Master, B.S.S., Y. Yasukochi, R.T. Okita, L.K. Parkhill, H. Taniguchi and J.H. Dees (1980) Laurate hydroxylation and drug metabolism in pig liver and kidney microsomes and in reconstituted systems from pig liver and kidney, in: M.J. Coon, A.H. Conney, R.W. Estabrook, H.V. Gelboin, J.R. Gillette and P.J. O'Brien (Eds.), Microsomes, Drug Oxidation, and Chemical Carcinogenesis, Vol. 1, Academic Press, New York, pp. 709-720.
79. H. Burgschat, K.J. Netter, Application of AC-polarography in a study of p-nitroanisole metabolism and its kinetic properties, J. Pharmacol. Exp. Ther. 201 (1977) 482-489.
80. M.R. Juchaud, K.G. Symms, Aniline hydroxylation in the human placenta - mechanistic aspects, Biochem. Pharmacol. 21 (1972) 2053-2064.
81. R.A. Prough, D.M. Ziegler, The relative participation of liver microsomal amine oxidase and cytochrome P-450 in N-demethylation reactions, Arch. Biochem. Biophys. 180 (1977) 363-373.
82. J.H. Dewaide, P.T.H. Henderson, Hepatic N-demethylation of aminopyrine in rat and trout, Biochem. Pharmacol. 17 (1968) 1901-1907.
83. D.R. Mattison, S. Torgeirsson, Gonad aryl hydroxylase in rats and mice, Cancer Res. 38 (1978) 1368-1373.
84. L. Balk, J. Meijer, J. Seideg, R. Morgestein, J.M. Depierre, Initial characterization of drug metabolizing systems in the liver of the Northern pike, Esox lucins. Drugs Metab. Dispos. 8 (1980) 98-103.
85. M. Komori, Y. Imai, R. Sato, Purification and characterization of cytochrome P-450 with high affinity for 7-alkoxycoumarin, J. Biochem. 95 (1984) 1379-1388.
86. B. Ioannoni, P.E. Reilli, D.J. Winsor, Evaluation of monooxygenases induction as a means of enhancing the yield of the rat liver cytochrome P-450 isoenzyme with high affinity of cimetidine, Biochem. Pharmacol. 32 (1983) 3103-3108.
87. J. Comte, D.C. Gautheron, The markers of pig heart mitochondrial sub-fractions: the dual location of NADPH-cytochrome c-reductase in other membrane and microsomes, Biochimie 60 (1978) 1289-1298.
88. R.T. Mayer, J.A. Svoboda, G.F. Weirich, Ecdysone 20-hydrolase in midgut mitochondria of Manduca sexta, Hoppe Seyler's Z. Physiol. Chem. 359 (1978) 1247-1257.
89. E.D. Williams, S.E. Hale, A.S. Muerhof, B.S.S. Mesters, Rabbit lung flavin-containing monooxygenase. Purification, characterization, and induction during pregnancy, Mol. Pharmacol. 28 (1985) 381-390.
90. R.E. Tynes, E. Hodgson, Oxidation of thiobenzamide by the FAD-containing and cytochrome P-450 dependent monooxygenases of liver and lung microsomes, Biochem. Pharmacol. 32 (1983) 3419-3428.
91. R.A. Prough, P.C. Freeman, R.N. Hines, The oxidation of hydrazine derivatives catalyzed by the purified liver microsomal FAD-containing monooxygenase, J. Biol. Chem. 256 (1981) 4178-4184.
92. P.J. Sabourin, E. Hodgson, Characterization of the purified microsomal FAD-containing monooxygenase from mouse and pig-liver, Chem.-Biol. Interact. 51 (1984) 125-139.
93. M.E. McManus, I. Stupans, W. Burgess, J.A. Koenig, P. Hall, M. De La, J.D. Birkett, Flavin containing monooxygenases activity in human liver microsomes, Drugs Metab. Dispos. 15 (1987) 256-261.
94. W.H. Habig, M.J. Pabst, W.B. Jakoby, Glutathione S-transferase. The first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (1974) 7130-7139.
95. M. Paolini, R. Mesirca, L. Pozzetti, P. Silingardi, S. Grilli, G. Cantelli-Forti, Strategies for advancement of short-term mutagenicity tests: on the optimal ionic strength for the liver microsomal assay, Carcinogenesis 13 (1992) 1403-1408.
96. B.A. Jackson, R. Pertel, Regulatory implications of Ames mutagenicity assay using Salmonella typhimurium, Fundam. Appl. Toxicol. 7 (1986) 1-16.